Author

Nikola Panajotovikj

Universitat de GironaORCID 0009-0003-0188-483XUnclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:machine learning (classical)· 1

Frequent Co-Authors

Aron Schulman· 1 shared Huiyan YingiD· 1 shared Jordi MestresiD· 1 shared Mirva PääkköneniD· 1 shared Mitro MiihkineniD· 1 shared Otto KaukoiD· 1 shared Tanisha Malpani· 1 shared Tero A. AittokallioiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

Aron Schulman

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Pharmacology & ToxicologybioRxivPreprintNov 12, 2025

Off-target mapping enhances selectivity of machine learning-predicted CK2 inhibitors

Huiyan Ying, Weikaixin Kong, Aron Schulman…·Mitro Miihkinen

The paper develops an ML-powered drug discovery pipeline to design selective CK2 inhibitors with favorable off-target profiles, achieving a 90% hit-rate.

DOI 10.1101/2025.11.12.688093

machine learning (classical)drug response / drug discovery

𝕏 PostBluesky